Ramadan Qasem, Zourob Mohammed
Alfaisal University, Al Zahrawi Street, Riyadh 11533, Kingdom of Saudi Arabia.
Biomicrofluidics. 2020 Jul 14;14(4):041501. doi: 10.1063/5.0011583. eCollection 2020 Jul.
Organ-on-a-chip (OOC) is a very ambitious emerging technology with a high potential to revolutionize many medical and industrial sectors, particularly in preclinical-to-clinical translation in the pharmaceutical arena. , the function of the organ(s) is orchestrated by a complex cellular structure and physiochemical factors within the extracellular matrix and secreted by various types of cells. The trend in modeling is to simplify the complex anatomy of the human organ(s) to the minimal essential cellular structure "micro-anatomy" instead of recapitulating the full cellular milieu that enables studying the absorption, metabolism, as well as the mechanistic investigation of drug compounds in a "systemic manner." However, in order to reflect the human physiology and hence to be able to bridge the gap between the and data, simplification should not compromise the physiological relevance. Engineering principles have long been applied to solve medical challenges, and at this stage of organ-on-a-chip technology development, the work of biomedical engineers, focusing on device engineering, is more important than ever to accelerate the technology transfer from the academic lab bench to specialized product development institutions and to the increasingly demanding market. In this paper, instead of presenting a narrative review of the literature, we systemically present a synthesis of the best available organ-on-a-chip technology from what is found, what has been achieved, and what yet needs to be done. We emphasized mainly on the requirements of a "good model that meets the industrial need" in terms of the structure (micro-anatomy), functions (micro-physiology), and characteristics of the device that hosts the biological model. Finally, we discuss the biological model-device integration supported by an example and the major challenges that delay the OOC technology transfer to the industry and recommended possible options to realize a functional organ-on-a-chip system.
器官芯片(OOC)是一项极具雄心的新兴技术,极有可能给众多医疗和工业领域带来变革,尤其是在制药领域从临床前到临床的转化过程中。器官的功能是由细胞外基质内复杂的细胞结构和理化因素共同协调,并由各种类型的细胞分泌产生。建模的趋势是将人体器官复杂的解剖结构简化为最小的基本细胞结构“微观解剖”,而非重现完整的细胞环境,以便能够“系统地”研究药物化合物的吸收、代谢以及进行机理研究。然而,为了反映人体生理学特征,从而能够弥合临床前和临床数据之间的差距,简化不应损害生理相关性。工程原理长期以来一直被应用于解决医学难题,在器官芯片技术发展的现阶段,专注于设备工程的生物医学工程师的工作对于加速技术从学术实验室向专业产品开发机构以及日益苛刻的市场的转移比以往任何时候都更为重要。在本文中,我们并非对文献进行叙述性综述,而是系统地综合了从已发现的、已取得的成果以及仍需完成的工作中得出的最佳可用器官芯片技术。我们主要强调了在结构(微观解剖)、功能(微观生理学)以及承载生物模型的设备特性方面,一个“满足工业需求的良好器官模型”的要求。最后,我们通过一个例子讨论了生物模型与设备的集成,以及阻碍器官芯片技术向产业转移的主要挑战,并推荐了实现功能性器官芯片系统的可能选择。